Clinical Implications of the Allergic Rhinitis-Asthma Link

American Journal of the Medical Sciences

Volumn 327, Issue 3, 2004, Pages 127-138

  Casale, Thomas B ^a   Dykewicz, Mark S ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergic rhinitis; Allergic rhinitis asthma link; Allergies; Asthma

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; BECLOMETASONE DIPROPIONATE; CETIRIZINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYTOKINE; DESLORATADINE; EOSINOPHIL CATIONIC PROTEIN; FEXOFENADINE; FLUNISOLIDE; FLUTICASONE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 5; LEUKOTRIENE C4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; METHACHOLINE; MONOCLONAL ANTIBODY; MONTELUKAST; NEDOCROMIL; OMALIZUMAB; PEPTIDOLEUKOTRIENE; PSEUDOEPHEDRINE; SALMETEROL; THEOPHYLLINE; UNINDEXED DRUG; ZAFIRLUKAST;

ALLERGIC RHINITIS; ASTHMA; CLINICAL TRIAL; DISEASE ASSOCIATION; DROWSINESS; DRUG EFFICACY; FAMILY HISTORY; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOTHERAPY; LUNG FUNCTION; PATHOPHYSIOLOGY; PREDICTION; REVIEW; RISK FACTOR;

EID: 1542343938     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200403000-00004     Document Type: Review

References (75)

1. Bousquet J, Van Cauwenberge P, Khaltaev N, et al. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147-336.
2. The Allergy Report. Overview of allergic diseases: diagnosis, management and barriers to care, vol. 1. Milwaukee (WI): American Academy of Allergy, Asthma, and Immunology; 2000.
3. Busse W. Epidemiology of rhinitis and asthma. Eur Respir Rev 1997;7:284-5.
4. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact J Allergy Clin Immunol 2001;107:3-8.
5. Yawn BP, Yunginger JW, Wollan PC, et al. Allergic rhinitis in Rochester, Minnesota, residents with asthma: frequency and impact on health care charges. J Allergy Clin Immunol 1999;103:54-9.
6. Wright AL, Holberg CJ, Martinez FD, et al. Epidemiology of physician-diagnosed allergic rhinitis in children. Pediatrics 1994;94:895-901.
7. Peat JK, Salome CM, Woolcock AJ. Longitudinal changes in atopy during a 4-year period: relation to bronchial hyperresponsiveness and respiratory symptoms in a population sample of Australian school-children. J Allergy Clin Immunol 1990;85:65-74.
8. Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year followup study of college students. Allergy Proc 1994;15:21-5.
9. Broder I, Higgins MW, Matthews KP, et al. Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan. J Allergy Clin Immunol 1974;54:100-1.
10. Pariente PD, LePen C, Los F, et al. Quality-of-life outcomes and the use of antihistamines in a French national population-based sample of patients with perennial rhinitis. Pharmacoeconomics 1997;12:585-95.
11. Leynaert B, Bousquet J, Neukirch C, et al. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104:301-4.
12. Lundback B. Epidemiology of rhinitis and asthma. Clin Exp Allergy 1998;2:3-10.
13. Illi S, von Mutius E, Lau S, et al. The pattern of atopic sensitization is associated with the development of asthma in childhood. J Allergy Clin Immunol 2001;108:709-14.
14. Casale TB. Immunobiology of asthma and rhinitis: pathogenic factors and therapeutic options. In: American Thoracic Society Workshop Summary; 1997 June. Montreal, Quebec, Canada. New York: American Lung Association; 1999.
15. Casale TB, Amin BV. Allergic rhinitis/asthma interrelationships. Clin Rev Allergy Immunol 2001;21:27-49.
16. Marshall GD. Therapeutic options in allergic disease: antihistamines as systemic antiallergic agents. J Allergy Clin Immunol 2000;106:S303-9.
17. Inman MD. Bone marrow events in animal models of allergic inflammation and hyperresponsiveness. J Allergy Clin Immunol 2000;106:S235-41.
18. Casale TB. Clinical implications of the allergic rhinitis/ asthma connection. Respir Dig 2001;3:1-9.
19. Segura T, Casale TB. Allergic rhinitis: basic pathophysiology and therapeutic implications. Can J Allergy Clin Immunol 1999;4:318-30.
20. Chanez P, Vignola AM, Vic P, et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. Am J Respir Crit Care Med 1999;159:588-95.
21. Gerblich AA, Schwartz HJ, Chester EH. Seasonal variation of airway function in allergic rhinitis. J Allergy Clin Immunol 1986;77:676-81.
22. Griffin MP, McFadden ER, Ingram RH. Airway cooling in asthmatic and nonasthmatic subjects during nasal and oral breathing. J Allergy Clin Immunol 1982;69:354-9.
23. Bardin PG, Van Heerden BB, Joubert JR. Absence of pulmonary aspiration of sinus contents in patients with asthma and sinusitis. J Allergy Clin Immunol 1990;86:82-8.
24. Brugman SM, Larsen GL, Henson PM, et al. Increased lower airways responsiveness associated with sinusitis in a rabbit model. Am Rev Respir Dis 1993;147:314-20.
25. Braunstahl GJ, Overbeek SE, KleinJan A, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001;107:469-76.
26. Sluder G. Asthma as a nasal reflex. JAMA 1919;73:589-91.
27. Yan K, Salome C. The response of the airways to nasal stimulation in asthmatics with rhinitis. Eur J Respir Dis 1983;64(Suppl):110-4.
28. Einarrson O, Geba GP, Zhou Z, et al. Interleukin-11 in respiratory inflammation. Ann N Y Acad Sci 1995;762:31-40.
29. Barnes PJ, Baraniuk JN, Belvisi MG. Neuropeptides in the respiratory tract. I. Am Rev Respir Dis 1991;144:1187-98.
30. Barnes PJ, Baraniuk JN, Belvisi MG. Neuropeptides in the respiratory tract. II. Am Rev Respir Dis 1991;144:1391-99.
31. Lilly CM, Kobizik L, Hall AE, et al. Effect of chronic airway inflammation on the activity and enzymatic inactivation of neuropeptides in guinea pig lungs. J Clin Invest 1994;93:2667-74.
32. Matsuda H, Coughlin MD, Bienenstock H, et al. Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc Natl Acad Sci U S A 1988;85:6508-12.
33. Casale TB, Condemi J, LaForce C, et al. For the Omalizumab Seasonal Allergic Rhinitis Trial Group. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. JAMA 2001;286:2956-67.
34. Bousquet J, Lockey RF, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. WHO Position Paper. J Allergy Clin Immunol 1998;102:558-62.
35. Möller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study). J Allergy Clin Immunol 2002;109:251-256.
36. Des Roches A, Paradise L, Menardo JL, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children J Allergy Clin Immunol 1997;99:450-3.
37. Grembiale RD, Camporota L, Naty S, et al. Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000;162:2048-52.
38. Milgrom H, Fick RB Jr., Su JQ, et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 study group. N Engl J Med 1999;341:1966-73.
39. Stirling RG, Chung KF. Future treatments of allergic diseases and asthma. Br Med Bull 2000;56:1037-53.
40. Crystal-Peters J, Neslusan C, Crown WH, et al. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002;109:57-62.
41. Adams RJ, Fuhlbrigge AL, Finkelstein JA, et al. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 2002;109:636-42.
42. Schleimer RP. Glucocorticosteroids: their mechanisms of action and use in allergic disease. In: E Middleton, Jr., Reed CE, Ellis EF et al, editors. Allergy: principles and practice. 5th ed. St. Louis (MO): Mosby-Year Book; 1998. p. 638-60.
43. Corren J, Adinoff AD, Buchemeier AD, et al. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992;90:250-6.
44. Watson WTA, Becker AB, Simons FER. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993;91:97-101.
45. Welsh PW, Stricker WE, Chu C-P, et al. Efficacy of beclomethasone nasal solution, flunisolide and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc 1987;62:125-34.
46. Henriksen JW, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing and asthma. Am Rev Respir Dis 1984;130:1014-8.
47. Aubier N, Levy J, Clerici C, et al. Different effects of nasal and bronchial glucocorticoid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992;146:122-6.
48. Greiff L, Andersson M, Svensson C, et al. Effects of orally inhaled budesonide in seasonal allergic rhinitis. Eur Respir J 1998;11:1268-74.
49. Casale TB, Wood D, Richerson HB, et al. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness. J Clin Invest 1987;79:1197-203.
50. Church MK. Non-H1-receptor effects of antihistamines. Clin Exp Allergy 1999;29(Suppl 3):39-48.
51. Grant JA, Nicodemus CF, Findlay SR, et al. Cetirizine in patients with seasonal allergic rhinitis and concomitant asthma: prospective randomized, placebo-controlled trial. J Allergy Clin Immunol 1995;95:923-32.
52. Corren J, Harris AG, Aaronson D, et al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol 1997;99:450-3.
53. Busse WW. The role of leukotrienes in asthma and allergic rhinitis. Clin Exp Allergy 1996;26:868-79.
54. Phipatanakul W, Eggleston PA, Conover-Walker MK, et al. A randomized double-blinded, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge. J Allergy Clin Immunol 2000;105:704-10.
55. Donnelly A, Glass M, Muller B, et al. The leukotriene D4 receptor antagonist ICI 204:219 relieves symptoms of acute seasonal allergic rhinitis. Am J Respir Crit Care Med 1995;151:1734-9.
56. Wilson AM, Orr LC, Sims EJ, et al. Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma. Am J Respir Crit Care Med 2000;162:1297-301.
57. Currie GP, Lee DK, Haggart K, et al. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma. Am J Respir Crit Care Med 2003;167:1232-8.
58. Philip G, Malmstrom K, Hampel FC, et al. For the Montelukast Spring Rhinitis Study Group. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy 2002;32:1020-8.
59. Nathan RA. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments. Ann Allergy Asthma Immunol 2003;90:182-91.
60. Larkins G, van Adelsberg J, Pedinoff A, et al. Efficacy of morning dosing of montelukast in seasonal allergic rhinitis (SAR). J Allergy Clin Immunol 2003;111:S84. Abstract 55.
61. Roquet A, Dahlen B, Kumlin M, et al. Combined antagonism of leukotrienes and histamine produced predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med 1997;155:1856-63.
62. Nayak AS, Philip G, Lu S, et al. For the Montelukast Fall Rhinitis Investigator Group. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol 2002;88:592-600.
63. Wilson AM, Orr LC, Coutie WJ, et al. A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis. Clin Exp Allergy 2002;32:126-32.
64. Pullerits T, Praks L, Ristioja V, et al. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 2002;109:949-55.
65. Aubier M, Neukirch C, Maachi M, et al. Effect of slow-release theophylline on nasal antigen challenge in subjects with allergic rhinitis. Eur Respir J 1998;11:1105-10.
66. Aubier M, Levy J, Clerici C, et al. Protective effect of theophylline on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1991;143:346-50.
67. Busse W, Corren J, Lanier BQ, et al. Omalizumab, antiIgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001;108:184-90.
68. Finn A, Gross G, van Bavel J, et al. Omalizumab improves asthma-related quality of life in patients with severe allergic asthma. J Allergy Clin Immunol 2003;111:278-84.
69. Lemanske RF Jr., Nayak A, McAlary M, et al. Omalizumab improves asthma-related quality of life in children with asthma. Pediatrics 2002;110:E55.
70. Corren J, Casale T, Deniz Y, et al. Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma. J Allergy Clin Immunol 2003;111:87-90.
71. Executive Summary of the National Asthma Education and Prevention Program (NAEPP). Expert Panel Report: Guidelines for the diagnosis and management of asthma-update on selected topics 2002. NIH publication no. 02-5075. Bethesda (MD): National Institutes of Health; 2002
72. Green R, Simpson A, Custovis A, et al. The effect of air filtration on airborne dog allergen. Allergy 1999;54:484-8.
73. Passalacqua G, Ciprandi G, Canonica GW. United airways disease: therapeutic aspects. Thorax 2000;55(Suppl 2):S26-7.
74. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 2003;111:1171-83.
75. Simons FER. Allergic rhinobronchitis: the asthma-allergic rhinitis link. J Allergy Clin Immunol 199;104:534-40.